Associated Papers
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
Mancini M et al.
Clinical and Translational Medicine, 2025
Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.
Vaca-Paniagua F et al.
Plos One, 2015
25961742 (PubMed )
Supplement: pone.0126762.s015.xlsx › S11_Table
Select a paper to view details